Literature DB >> 3142965

Human immunodeficiency virus infection of the brain. II. Detection of intrathecally synthesized antibodies by enzyme linked immunosorbent assay and imprint immunofixation.

F Chiodi1, G Norkrans, L Hagberg, A Sönnerborg, H Gaines, S Frøland, E M Fenyö, E Norrby, B Vandvik.   

Abstract

Sera and CSF from 29 patients in early and late stages of HIV infection were analysed for intrathecal antibody production. Elevated CSF-IgG indices indicating intrathecal IgG synthesis were demonstrated in 9 patients while 4 of 18 patients tested had oligoclonal IgG bands in the CSF. Analysis of HIV-specific antibodies by enzyme-linked immunosorbent assay (whole antigen and site-directed ELISA) and calculation of "antibody indices" (CSF/serum antibody quotient divided by CSF/serum albumin quotient) indicated intrathecal HIV antibody synthesis in 19 patients. Analysis of serum and CSF antibodies by an imprint immunofixation (IIF) method showed intrathecal synthesis of predominantly polyclonal HIV-IgG antibodies in 11 of 13 patients examined. IIF analysis of antibodies to six other infectious agents showed no intrathecal antibody production except in one patient who had minor fractions of intrathecally synthesized IgG antibodies to varicella zoster virus. The present results demonstrate that an intrathecal HIV-specific antibody response may be present in both early and late stages of HIV infection, and indicates that HIV may reach the brain at an early stage of infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3142965     DOI: 10.1016/0022-510x(88)90052-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

1.  Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals.

Authors:  F Chiodi; B Keys; J Albert; L Hagberg; J Lundeberg; M Uhlén; E M Fenyö; G Norkrans
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

Review 2.  Insights into the role of immune activation in HIV neuropathogenesis.

Authors:  Suzanne Gartner; Yiling Liu
Journal:  J Neurovirol       Date:  2002-04       Impact factor: 2.643

3.  Intrathecal synthesis of virus-specific oligoclonal antibodies in patients with enterovirus infection of the central nervous system.

Authors:  R Kaiser; R Dörries; R Martin; U Fuhrmeister; K F Leonhardt; V ter Meulen
Journal:  J Neurol       Date:  1989-10       Impact factor: 4.849

4.  Analysis of oligoclonal antibody bands against individual HIV structural proteins in the CSF of patients infected with HIV.

Authors:  R Kaiser; R Dörries; W Lüer; S Poser; H D Pohle; K Felgenhauer; V ter Meulen
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

5.  Effects of human immunodeficiency virus encephalitis and drug abuse on the B lymphocyte population of the brain.

Authors:  Iain C Anthony; Dorothy H Crawford; Jeanne E Bell
Journal:  J Neurovirol       Date:  2004-06       Impact factor: 2.643

Review 6.  Cerebrospinal fluid (CSF) analyses in HIV-1 primary neurological disease.

Authors:  J Nogales-Gaete; K Syndulko; W W Tourtellotte
Journal:  Ital J Neurol Sci       Date:  1992-11

7.  Immunoglobulin G subclass preference of intrathecally produced HIV-specific oligoclonal antibodies.

Authors:  R Kaiser; R Dörries; B Ruf; H D Pohle; R Martin; V ter Meulen
Journal:  J Neurol       Date:  1991-09       Impact factor: 4.849

Review 8.  Hypothesis on the pathogenesis of vacuolar myelopathy, dementia, and peripheral neuropathy in AIDS.

Authors:  S V Tan; R J Guiloff
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-07       Impact factor: 10.154

9.  Predictive value of neurological abnormalities in HIV 1 patients in the early stages of the infection.

Authors:  G Tilia; M Spadaro; G Soldati; E Pinter; C Morocutti
Journal:  Ital J Neurol Sci       Date:  1993-03

10.  IgG intrathecal synthesis in HIV-associated neurocognitive disorder (HAND) according to the HIV-1 subtypes and pattern of HIV RNA in CNS and plasma compartments.

Authors:  Sergio M De Almeida; Indianara Rotta; Bin Tang; Florin Vaida; Scott Letendre; Ronald J Ellis
Journal:  J Neuroimmunol       Date:  2021-03-08       Impact factor: 3.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.